TrialCompass TCL
Back to results
RecruitingPriority 4 · Lower priorityNCT07270861

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

ClinicalTrials.gov

Plain-language summary

This trial is evaluating Observational as a treatment for people newly diagnosed with T-cell lymphoma. The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join (key eligibility)

  • Age 18 Years or older
  • Newly diagnosed, not yet treated

Final eligibility is determined by the trial team. This list is a starting point only.

What's being tested

Observational (OTHER): Observational

Drugs / treatments
Observational
Treatment length
Ask the trial team for details
Visit frequency
Ask the trial team for details
TrialCompass — Clinical Trial Summary

Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

NCT07270861

Phase: | Status: Recruiting | Priority: Lower

Plain-language summary

This trial is evaluating Observational as a treatment for people newly diagnosed with T-cell lymphoma. The study measures how well this treatment works and monitors for side effects. This trial does not currently list US sites.

Who can join

  • Age 18 Years or older
  • Newly diagnosed, not yet treated

What's being tested

Observational (OTHER): Observational

Drugs / treatments: Observational

Treatment length: Ask the trial team for details

Visit frequency: Ask the trial team for details

Trial design

Non-randomized, blind

Enrollment target: 3000 patients

Primary endpoint: Distribution of PTCL Histological Subtypes according to WHO 2016 Classification; Overall Survival (OS); Progression-Free Survival (PFS)

Ages: 18 Years to —

Start date: 2025-11-15 | Est. completion: 2035-12-31

Locations

0 US sites · 1 total

Contact

Rong Tao, MD | hkutao@hotmail.com | 008621-64175590

Sponsor: Fudan University (OTHER)

Tags

All T-cell lymphomas · Newly diagnosed · Relapsed/Refractory

View on ClinicalTrials.gov

https://clinicaltrials.gov/study/NCT07270861

Prepared using TrialCompass (trialcompass.com) on June 19, 2026. For informational purposes only. Always discuss with your healthcare team.